Publication:
A novel EGFR Inhibitor, HNPMI regulates apoptosis and oncogenesis by modulating BCL-2/BAX and p53 in colon cancer.

Simple item page
dc.contributor.authorKandhavelu J.
dc.contributor.authorSubramanian K.
dc.contributor.authorNaidoo V.
dc.contributor.authorSebastianelli G.
dc.contributor.authorDoan P.
dc.contributor.authorMani S. K.
dc.contributor.authorYapislar H.
dc.contributor.authorHaciosmanoglu E.
dc.contributor.authorArslan L.
dc.contributor.authorOzer S.
dc.contributor.authoret al.
dc.contributor.institutionauthorHACIOSMANOĞLU, EBRU
dc.date.accessioned2023-08-28T21:50:10Z
dc.date.available2023-08-28T21:50:10Z
dc.date.issued2023-05-15
dc.identifier.citationKandhavelu J., Subramanian K., Naidoo V., Sebastianelli G., Doan P., Mani S. K., Yapislar H., Haciosmanoglu E., Arslan L., Ozer S., et al., "A novel EGFR Inhibitor, HNPMI regulates apoptosis and oncogenesis by modulating BCL-2/BAX and p53 in colon cancer.", British journal of pharmacology, 2023
dc.identifier.doi10.1111/bph.16141
dc.identifier.issn0007-1188
dc.identifier.pubmed37183661
dc.identifier.urihttps://hdl.handle.net/20.500.12645/38533
dc.relation.ispartofBritish journal of pharmacology
dc.rightsinfo:eu-repo/semantics/openAccess
dc.titleA novel EGFR Inhibitor, HNPMI regulates apoptosis and oncogenesis by modulating BCL-2/BAX and p53 in colon cancer.
dc.typeArticle
dspace.entity.typePublication
local.avesis.idef480f3f-0c8a-4725-865e-378b30e98bfa
relation.isAuthorOfPublicationfffb1a2f-62c4-40ee-8fc4-f0f3e62523b9
relation.isAuthorOfPublication.latestForDiscoveryfffb1a2f-62c4-40ee-8fc4-f0f3e62523b9
Files
Collections
Yayınlar - Eserler